BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25308776)

  • 1. Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model.
    Steven Ernest C; Nyberg J; Karlsson MO; Hooker AC
    J Pharmacokinet Pharmacodyn; 2014 Dec; 41(6):639-54. PubMed ID: 25308776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Fisher information matrix approximation methods in population optimal design calculations.
    Strömberg EA; Nyberg J; Hooker AC
    J Pharmacokinet Pharmacodyn; 2016 Dec; 43(6):609-619. PubMed ID: 27804003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust designs in longitudinal studies accounting for parameter and model uncertainties - application to count data.
    Loingeville F; Nguyen TT; Riviere MK; Mentré F
    J Biopharm Stat; 2020; 30(1):31-45. PubMed ID: 31032703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients.
    Bizzotto R; Zamuner S; De Nicolao G; Karlsson MO; Gomeni R
    J Pharmacokinet Pharmacodyn; 2010 Apr; 37(2):137-55. PubMed ID: 20052524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An MCMC method for the evaluation of the Fisher information matrix for non-linear mixed effect models.
    Riviere MK; Ueckert S; Mentré F
    Biostatistics; 2016 Oct; 17(4):737-50. PubMed ID: 27166250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.
    Dumont C; Lestini G; Le Nagard H; Mentré F; Comets E; Nguyen TT;
    Comput Methods Programs Biomed; 2018 Mar; 156():217-229. PubMed ID: 29428073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust and Adaptive Two-stage Designs in Nonlinear Mixed Effect Models.
    Fayette L; Leroux R; Mentré F; Seurat J
    AAPS J; 2023 Jul; 25(4):71. PubMed ID: 37466809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.
    Karlsson MO; Schoemaker RC; Kemp B; Cohen AF; van Gerven JM; Tuk B; Peck CC; Danhof M
    Clin Pharmacol Ther; 2000 Aug; 68(2):175-88. PubMed ID: 10976549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of variability in length of sleep state bouts reveals memory-free sleep subcomponents consistent among primary insomnia patients.
    Bizzotto R; Zamuner S
    J Neurophysiol; 2018 May; 119(5):1836-1851. PubMed ID: 29384456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tutorial for $DESIGN in NONMEM: Clinical trial evaluation and optimization.
    Bauer RJ; Hooker AC; Mentre F
    CPT Pharmacometrics Syst Pharmacol; 2021 Dec; 10(12):1452-1465. PubMed ID: 34559958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.
    Retout S; Mentré F; Bruno R
    Stat Med; 2002 Sep; 21(18):2623-39. PubMed ID: 12228881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pragmatic approach to the design of population pharmacokinetic studies.
    Roy A; Ette EI
    AAPS J; 2005 Oct; 7(2):E408-20. PubMed ID: 16353920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computer tool for a minimax criterion in binary response and heteroscedastic simple linear regression models.
    Casero-Alonso V; López-Fidalgo J; Torsney B
    Comput Methods Programs Biomed; 2017 Jan; 138():105-115. PubMed ID: 27886709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis.
    Bizzotto R; Zamuner S; Mezzalana E; De Nicolao G; Gomeni R; Hooker AC; Karlsson MO
    AAPS J; 2011 Sep; 13(3):445-63. PubMed ID: 21691915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding optimal design in nonlinear mixed effect models using multiplicative algorithms.
    Seurat J; Tang Y; Mentré F; Nguyen TT
    Comput Methods Programs Biomed; 2021 Aug; 207():106126. PubMed ID: 34038863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation of human hypnograms using a Markov chain model.
    Kemp B; Kamphuisen HA
    Sleep; 1986; 9(3):405-14. PubMed ID: 3764288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is moderate depression associated with sleep stage architecture in adolescence? Testing the stage type associations using network and transition probability approaches.
    Elovainio M; Lipsanen J; Halonen R; Kuula L; Räikkönen K; Pesonen AK
    Psychol Med; 2021 Feb; 51(3):426-434. PubMed ID: 31843034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient determination of the uncertainty for the optimization of SPECT system design: a subsampled fisher information matrix.
    Fuin N; Pedemonte S; Arridge S; Ourselin S; Hutton BF
    IEEE Trans Med Imaging; 2014 Mar; 33(3):618-35. PubMed ID: 24595338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a flexible piecewise linear mixed-effects model in the analysis of randomized cross-over trials.
    Mwangi M; Verbeke G; Njagi EN; Florez AJ; Mwalili S; Ivanova A; Bukania ZN; Molenberghs G
    Pharm Stat; 2024; 23(3):370-384. PubMed ID: 38146135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A numerical approach for a discrete Markov model for progressing drug resistance of cancer.
    Maeda M; Yamashita H
    PLoS Comput Biol; 2019 Feb; 15(2):e1006770. PubMed ID: 30779730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.